Alimera Sciences, Inc. ( ALIM) - Stock Earnings
Stock symbol ALIM is outdated, potentially delisted? Maybe it is available on other exchange?
ALIM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -3.8 million USD | 26.3 million USD |
| 2024Q1 | -6.3 million USD | 23.0 million USD |
| 2024Q2 | -3.3 million USD | 27.0 million USD |
ALIM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -4.4 million USD | 59.0 million USD |
| 2022 | -18.1 million USD | 54.1 million USD |
| 2023 | -20.1 million USD | 80.8 million USD |
ALIM
Price: $5.54
52 week price:
Earnings Per Share: 1.05 USD
P/E Ratio: 5.30
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 7882
Ebitda: -3.1 millionMarket Capitalization: 302.4 million